+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North American Defibrillators Market 2019-2025

  • PDF Icon


  • January 2020
  • Region: North America
  • Orion Market Research Private Limited
  • ID: 4969040
The North American region is expected to contribute higher in the global defibrillator market with major revenue generation from the U. S. region. The growth is attributed to the increasing number of aged populations. According to WHO,the incidence and prevalence rate of heart attacks are highest in North America, which is responsible for 0.7 million fatalities each year. According to Heart & Stroke Foundation in Canada alone, 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart disease.

Further, Automated external defibrillator (AED)are widely adopted procedures in the defibrillator market and have a considerable market share. Growing CVD, CHD, stroke and other heart diseases, highest healthcare spending, technological advancement and adoption of hybrid operating rooms and minimally invasive surgeries are the key drivers of the North American Market. However, providing heart stroke related services in urban and rural regions is still a challenge to North America owing to huge demand.

The North American defibrillator market is growing significantly across the globe due to rising heart patients, FDA approvals, growing adoption of minimally invasive/non-invasive surgeries and technological advancement in the defibrillator market. Due to huge adoption of AED and technical advancement in the defibrillation technology, and North America having the highest number of patients with heart diseases ,giving rise to the adoption of robotic automation in the AED. North America has a considerable market share for capacitor, inductor and power supply market segment. Adoption of innovative technologies are boosting the market growth. Further, the presence of the key players also contributes to the growth of the market during the forecast period.

The only commercially available wearable defibrillator to date is the LifeVest, manufactured by ZOLL Medical Corporation and approved by the US FDA in 2002. It consists of an elastic belt and shoulder strap that carries four dry, non-adhesive sensing electrodes and three defibrillator electrodes. The electrodes exude gels automatically just before the delivery of a shock. The US FDA classifies medical devices into three class that is Class I, Class II and Class III. Most of the defibrillators are placed under Class II or Class III category by the US FDA.

Research Methodology

The market study of the North American Defibrillators market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. North American Defibrillators Market Research and Analysis by Type
2. North American Defibrillators Market Research and Analysis by End-users

The Report Covers
  • Comprehensive research methodology of the North American Defibrillators market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the North American Defibrillators market.
  • Insights about market determinants which are stimulating the North American Defibrillators market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. North American Defibrillators Market by Type
5.1.1. Implantable Cardioverter Defibrillators
5.1.2. External Cardioverter Defibrillators
5.2. North American Defibrillators Market by End-Users
5.2.1. Hospitals
5.2.2. Ambulatory Services and Others
6. Regional Analysis
6.1. United States
6.2. Canada
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Biotronik SE & Co. KG
7.3. Cintas Corp.
7.4. Defibtech, LLC
7.5. General Electric Co.
7.6. Koninklijke Philips N.V.
7.7. LivaNova PLC
7.8. Medtronic PLC
7.9. Mindray Medical International Co. Ltd.
7.10. Nihon Kohden Corp.
7.11. Stryker Corp.
7.12. ZOLL Medical Corp. (an Asahi Kasei Group company)

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Biotronik SE & Co. KG
  • Cintas Corp.
  • Defibtech, LLC
  • General Electric Co.
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic PLC
  • Mindray Medical International Co. Ltd.
  • Nihon Kohden Corp.
  • Stryker Corp.
  • ZOLL Medical Corp. (an Asahi Kasei Group company)